• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Artificial Heart Market Share

    ID: MRFR/HC/6513-HCR
    90 Pages
    Rahul Gotadki
    October 2025

    Artificial Heart Market Research Report Information by Type (Heart-Lung Machine, Mechanical Heart, Total Artificial Hearts, Ventricular Assist Devices (VADs)), End User (Hospitals & Clinics, Specialty Centers) and Region (Americas, Europe, Asia-Pacific, Middle East Africa) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Artificial Heart Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Share

    Artificial Heart Market Share Analysis

    In the competitive landscape of the Artificial Heart market, market share positioning strategies play a crucial role in determining the success of companies. This involves a strategic approach to carve out a distinct space in the market and gain a competitive edge. When companies are aiming to minimize market share slippage, product differentiation becomes a big issue. This involves the designing of artificial hearts that have a distinctiveness, superseded performance and better result in patients. Companies can create separate one fan’s base due to something special provided and broaden their market share. Cost Leadership is a basic and very relevant market share position strategy. Companies always trying to achieve minimum optimizing manufacturing processes, control production costs and improve operations efficiencies. Price-based competition for an artificial heart’s low price and therefore a price awareness market allows to achieve market dominance. For a competitive market space in the medical field, it is highly critical for healthcare products to meet strict regulatory standards and still rank with high quality. Enhancing market shares positively can be achieved through reputable companies that believe in regulatory compliance and have the reputation of product quality, hence providers for the healthcare professionals and patients’ trust. The adoption of artificial hearts can help educate the market about their advantages and also spread awareness towards emerging technologies; thus eventually reducing percentage growth. Companies spend money on advertising campaigns meant to both educate health care professionals and as well as the public in general, with being able to engender trust and credibility. In the healthcare industry, including artificial heart technology and other similar domains, trends mutate over time. Businesses that earn room for agility and adaptability, which can arise from shifting patient adoption tendencies, or developments with changes in technology, or regulation, create situations where they are able to hold on a majority of the market share during such changes in the market. Providing excellent post-sales support and services is a key aspect of market share positioning. Companies that offer comprehensive training, maintenance services, and responsive customer support contribute to customer satisfaction and loyalty, impacting market share through positive word-of-mouth and repeat business.

    Market Summary

    The Global Artificial Heart Market is projected to grow from 5 USD Billion in 2024 to 7.47 USD Billion by 2032.

    Key Market Trends & Highlights

    Artificial Heart Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 3.71% from 2025 to 2032.
    • By 2035, the market valuation is anticipated to reach 7.47 USD Billion, reflecting a steady increase.
    • In 2024, the market is valued at 5 USD Billion, indicating a robust foundation for future growth.
    • Growing adoption of artificial hearts due to advancements in medical technology is a major market driver.

    Market Size & Forecast

    2024 Market Size 5 (USD Billion)
    2035 Market Size 7.47 (USD Billion)
    CAGR (2025-2035) 3.71%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    SynCardia Systems, CryoLife, LLC, ABIOMED, CARMAT, Abbott, Cleveland Heart Inc., Thoratec Corporation

    Market Trends

    Drivers- the high increase in market demand of the artificial heart is due to the highly increased cardiovascular disorder among the population along with the increase in the aging population suffering from final stage heart failure. People engaging themselves in smoking along with reimbursement policies so implemented drives up the artificial heart valve market rate and its market value. People developing a high risk of heart complications increase the market growth of artificial heart.

    Opportunities- medical device manufacturer is the lucrative opportunity that helps in driving up market growth. Some of the market drivers are an adaptation of new healthcare technology along with taking government initiatives to increase the opportunities of the market. Increased unavailability of favorable insurance policies widens up the opportunities for expanding the market growth of artificial heart.

    Challenges- prevalence of HVD globally and regionally and certain regulatory approvals is the challenging factor towards the market growth.

    Cumulative growth- the presence of high market value of high USD and high CAGR projects at a high rate covering large market share.

    Restraints- strict rules so imposed by the government and the regulatory scenario so imposed as per the FDA policies are the factors that act as a restraining factor affecting the growth of the market. High costs of artificial heart valves along with the high treatment facilities and the regulations so imposed spoils up the market growth.

    The ongoing advancements in biocompatible materials and miniaturization technologies are poised to enhance the efficacy and accessibility of artificial hearts, potentially transforming cardiac care for patients worldwide.

    U.S. National Institutes of Health

    Artificial Heart Market Market Drivers

    Rising Prevalence of Cardiovascular Diseases

    The increasing incidence of cardiovascular diseases globally is a primary driver for the Global Artificial Heart Market Industry. As heart-related ailments continue to escalate, the demand for advanced cardiac solutions, including artificial hearts, is likely to rise. In 2024, the market is projected to reach 5 USD Billion, reflecting the urgent need for innovative treatments. This trend is expected to persist as the World Health Organization indicates that cardiovascular diseases remain the leading cause of death worldwide. Consequently, healthcare systems are compelled to invest in artificial heart technologies to address this growing health crisis.

    Market Segment Insights

    Artificial Heart Type Insights

    globally and regionally, the Artificial Heart Market has been classified into type and end-user. As per the type, the market is classified into the heart-lung machine and mechanical heart. The mechanical heart is further classified into total artificial hearts and ventricular assist devices.

     The mechanical heart part projects at a high CAGR value during the market forecast period which contributes much more to the rise in market demand. Based on the end-users, the heart valve market is divided into hospitals and clinics and some healthcare centers, and many more.

    Globally, the types of artificial heart valves expand to the region of America, Europe, Asia Pacific, some of the Middle East, and African regions. The Artificial Heart Market also expands to the regions of North America and some of Latin America areas where their region of North America includes the region of the United States and Canada.

    The market expanded to the European region and is divided into Western Europe and Eastern Europe. The Western European region includes some of the areas of Germany, France, Italian areas, the United Kingdom, Spain, and other regions of Western Europe.

     The market in the Asia Pacific market is divided into Japan, China, India, the South Korean region, Australia, and the rest of the Asia Pacific region.

    Artificial Heart Technology Insights

    due to advancement in technology advanced heart surgeries were used. It led to the invention of different types of artificial heart valves which functioned uniquely. Technology arouses awareness about the diagnosis facilities and the treatments. Technology led to the introduction of an innovative new artificial heart of low costs. The artificial heart cost and the cost of the artificial heart valve were not that huge.

    Get more detailed insights about Artificial Heart Market Research Report - Forecast till 2032

    Regional Insights

    Key Companies in the Artificial Heart Market market include

    Industry Developments

    • Q2 2024: SynCardia Announces FDA Approval for Next-Generation Total Artificial Heart SynCardia Systems received FDA approval for its next-generation Total Artificial Heart, designed to improve patient outcomes and device durability. The approval marks a significant milestone for the company and expands treatment options for patients with end-stage heart failure.
    • Q1 2024: Carmat Receives CE Mark Extension for Aeson Artificial Heart Carmat announced that it has received an extension of its CE Mark for the Aeson artificial heart, allowing continued commercial sales and use in European markets. The extension supports ongoing adoption of the device for patients with advanced heart failure.
    • Q2 2024: Carmat Resumes Aeson Artificial Heart Production After Manufacturing Suspension Carmat resumed production of its Aeson artificial heart following a temporary suspension due to quality control issues. The company implemented corrective actions and received regulatory clearance to restart manufacturing and distribution.
    • Q2 2024: SynCardia Systems Appoints New CEO to Drive Global Expansion SynCardia Systems announced the appointment of a new Chief Executive Officer, aiming to accelerate the company's global expansion and commercialization of its artificial heart technologies.
    • Q1 2024: Carmat Raises €30 Million to Fund Artificial Heart Commercialization Carmat completed a €30 million funding round to support the commercialization and scale-up of its Aeson artificial heart in Europe and other markets.
    • Q2 2024: Carmat Signs Distribution Agreement for Aeson Artificial Heart in Italy Carmat entered into a distribution agreement with a leading Italian medical device distributor to expand the availability of the Aeson artificial heart in Italy.
    • Q1 2024: FDA Grants Breakthrough Device Designation to BiVACOR Total Artificial Heart The FDA granted Breakthrough Device Designation to BiVACOR's Total Artificial Heart, recognizing its potential to provide more effective treatment for patients with severe heart failure.
    • Q2 2024: BiVACOR Announces First Human Implantation of Total Artificial Heart in U.S. Clinical Trial BiVACOR announced the successful first human implantation of its Total Artificial Heart as part of a U.S. clinical trial, marking a major milestone in the development of next-generation artificial heart technology.
    • Q2 2024: Carmat Opens New Manufacturing Facility for Aeson Artificial Heart Carmat inaugurated a new manufacturing facility dedicated to the production of its Aeson artificial heart, aiming to increase capacity and meet growing demand in Europe.
    • Q1 2024: SynCardia Systems Expands Distribution Network in Asia-Pacific SynCardia Systems announced the expansion of its distribution network in the Asia-Pacific region, partnering with local medical device companies to increase access to its Total Artificial Heart.
    • Q2 2024: Carmat Signs Strategic Partnership with Leading U.S. Cardiac Center Carmat entered into a strategic partnership with a major U.S. cardiac center to advance clinical research and adoption of the Aeson artificial heart in the United States.
    • Q1 2024: BiVACOR Secures $22 Million in Series B Funding to Advance Artificial Heart Development BiVACOR raised $22 million in Series B funding to accelerate the development and clinical testing of its Total Artificial Heart, supporting ongoing trials and regulatory submissions.

    Future Outlook

    Artificial Heart Market Future Outlook

    The Global Artificial Heart Market is projected to grow at a 3.71% CAGR from 2024 to 2032, driven by technological advancements, increasing prevalence of heart diseases, and rising healthcare expenditure.

    New opportunities lie in:

    • Develop innovative biocompatible materials for enhanced heart longevity.
    • Expand telemedicine solutions for remote monitoring of artificial heart patients.
    • Invest in partnerships with hospitals for integrated care pathways and patient education.

    By 2035, the market is expected to exhibit robust growth, reflecting advancements and increased adoption of artificial heart technologies.

    Market Segmentation

    REPORT OVERVIEW

    Artificial Heart Market Industry Developments
    • {"Q2 2024: SynCardia Announces FDA Approval for Next-Generation Total Artificial Heart"=>[]}
    • {"Q1 2024: Carmat Receives CE Mark Extension for Aeson Artificial Heart"=>[]}
    • {"Q2 2024: Carmat Resumes Aeson Artificial Heart Production After Manufacturing Suspension"=>[]}
    • {"Q2 2024: SynCardia Systems Appoints New CEO to Drive Global Expansion"=>[]}
    • {"Q1 2024: Carmat Raises €30 Million to Fund Artificial Heart Commercialization"=>[]}
    • {"Q2 2024: Carmat Signs Distribution Agreement for Aeson Artificial Heart in Italy"=>[]}
    • {"Q1 2024: FDA Grants Breakthrough Device Designation to BiVACOR Total Artificial Heart"=>[]}
    • {"Q2 2024: BiVACOR Announces First Human Implantation of Total Artificial Heart in U.S. Clinical Trial"=>[]}
    • {"Q2 2024: Carmat Opens New Manufacturing Facility for Aeson Artificial Heart"=>[]}
    • {"Q1 2024: SynCardia Systems Expands Distribution Network in Asia-Pacific"=>[]}
    • {"Q2 2024: Carmat Signs Strategic Partnership with Leading U.S. Cardiac Center"=>[]}
    • {"Q1 2024: BiVACOR Secures $22 Million in Series B Funding to Advance Artificial Heart Development"=>[]}

    Report Scope

    Report Attribute/Metric Details
      Market Size   USD 5 Billion
      CAGR   14.30%
      Base Year 2023
      Forecast Period   2023-2032
      Historical Data   2020
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, and End user
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   SynCardia Systems, LLC, BiVACOR Inc., CARMAT, Cleveland Heart, Inc., ABIOMED, CryoLife, Inc., Abbott, and Thoratec Corporation
      Key Market Opportunities   Medical device manufacturer
      Key Market Drivers ·  Adaptation of healthcare technology ·  Government initiatives to increase the healthcare quality ·  Availability of favorable insurance policies

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What was the valuation in 2030?

    The valuation was USD 4.98 billion.

    What is the predicted CAGR for the Artificial Heart Market for the forecast period (2022-2030)?

    The predicted CAGR would be 14.3%.

    What could slow down market growth?

    The high cost of the procedure and regulations regarding the process can slow down the growth.

    Which type to lead the market?

    The mechanical heart segment has the chance to record a higher CAGR.

    Which region would take charge of the artificial heart market?

    The Americas market would dominate the global field.

    1. Definition
      1. Scope of the Study
        1. Assumptions
        2. Limitations
    2. Research Methodology
      1. Introduction
      2. Primary Research
      3. 3.3
      4. Secondary Research
      5. Market Size Estimation
      6. Chapter 4. Market Dynamics
      7. Drivers
      8. Restraints
      9. Opportunities
      10. Challenges
      11. Macroeconomic Indicators
      12. Detection Technique Trends & Assessment
      13. Chapter 5. Market Factor Analysis
      14. Porter’s Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity
      15. of Rivalry
      16. Value Chain Analysis
      17. Investment Feasibility Analysis
      18. Pricing Analysis
    3. Chapter 6. Global Artificial Heart Market, by Type
      1. Introduction
      2. Heart-Lung Machine
      3. Market Estimates & Forecast,
      4. by Region, 2020-2027
    4. Market Estimates & Forecast, by Country, 2020-2027
      1. Mechanical Heart
    5. Market Estimates & Forecast, by Region, 2020-2027
    6. Market Estimates & Forecast, by Country, 2020-2027
      1. Hearts
    7. Total Artificial
    8. Market Estimates & Forecast, by Region, 2020-2027
      1. Market Estimates
      2. & Forecast, by Country, 2020-2027
    9. Ventricular Assist Devices (VADs)
    10. Market Estimates & Forecast, by Region, 2020-2027
      1. Market Estimates &
      2. Forecast, by Country, 2020-2027
      3. Chapter 7. Global Artificial Heart Market,
      4. by End User
      5. Introduction
      6. Hospitals & Clinics
      7. Market Estimates
      8. & Forecast, by Region, 2020-2027
    11. Market Estimates & Forecast, by Country,
      1. Specialty Centers
    12. Market Estimates & Forecast, by Region,
    13. Market Estimates & Forecast, by Country, 2020-2027
      1. Others
    14. Market Estimates & Forecast, by Region, 2020-2027
      1. Market Estimates &
      2. Forecast, by Country, 2020-2027
      3. Chapter 8. Global Artificial Heart
    15. Market, by Region
      1. Introduction
      2. Americas
        1. North America
        2. Latin America
      3. Europe
      4. 8.3.1
      5. Western Europe
      6. 8.3.1.4
      7. Spain
      8. 8.4.4
      9. Australia
      10. East & Africa
      11. Chapter 9 Company
      12. Landscape
      13. & Strategies
      14. Chapter 10. Company Profiles
      15. LLC
      16. Overview
      17. Inc.
      18. Overview
      19. Overview
      20. Heart, Inc.
      21. 10.4.3
      22. Financial Overview
      23. 10.5
      24. ABIOMED
      25. 10.5.3
      26. Financial overview
      27. 10.6
      28. CryoLife, Inc.
      29. Overview
      30. Analysis
      31. Chapter 11 MRFR Conclusion
      32. 11.2
      33. Key Companies to Watch
      34. Chapter 12. Appendix
    16. Germany
    17. France
    18. Italy
    19. UK
    20. Rest of Western Europe
    21. Eastern Europe
      1. Asia-Pacific
        1. Japan
        2. China
        3. India
        4. South Korea
        5. Rest of Asia-Pacific
      2. Middle
        1. Middle East
        2. Africa
      3. Introduction
      4. Market Share Analysis
      5. Key Development
      6. SynCardia Systems,
        1. Company Overview
        2. Treatment Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      7. BiVACOR
        1. Company Overview
        2. Treatment Overview
        3. Financial
        4. Key Developments
        5. SWOT Analysis
      8. CARMAT
        1. Company Overview
        2. Treatment Overview
        3. Financial
        4. Key Development
        5. SWOT Analysis
      9. Cleveland
        1. Company Overview
        2. Treatment Overview
        3. Key Development
        4. SWOT Analysis
        5. Company Overview
        6. Treatment Overview
        7. Key Developments
        8. SWOT Analysis
        9. Company Overview
        10. Treatment Overview
        11. Financial Overview
        12. Key Developments
        13. SWOT Analysis
      10. Abbott
        1. Company Overview
        2. Treatment Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      11. Thoratec Corporation
        1. Company Overview
        2. Treatment
        3. Financials
        4. Key Developments
        5. SWOT
      12. Key Findings
        1. From CEO’s Viewpoint
        2. Unmet Needs of the Market
      13. Predictions for the Artificial Heart Industry
    22. LIST OF TABLES
      1. Table 1
      2. Global Artificial Heart Market Synopsis, 2020-2027
    23. Global Artificial
      1. Heart Market Estimates and Forecast, 2020-2027
      2. (USD Million)
      3. Table 3
    24. Global Artificial Heart Market, by Region, 2020-2027 (USD Million)
      1. Table 4
    25. Global Artificial Heart Market, by Type, 2020-2027 (USD Million)
    26. Global
    27. Artificial Heart Market, by End-User, 2020-2027 (USD
      1. Million)
      2. Table
    28. North America: Artificial Heart Market, by Type, 2020-2027 (USD
      1. Million)
    29. North America: Artificial Heart Market, by End User, 2020-2027
      1. (USD
      2. Million)
    30. US: Artificial Heart Market, by Type, 2020-2027 (USD
      1. Million)
    31. US: Artificial Heart Market, by End User, 2020-2027 (USD
      1. Million)
    32. Canada: Artificial Heart Market, by Type, 2020-2027
      1. (USD Million)
    33. Canada: Artificial Heart Market, by End User, 2020-2027
      1. (USD
      2. Million)
    34. Latin America: Artificial Heart Market, by Type,
      1. Million)
    35. Latin America: Artificial Heart Market,
      1. by End User, 2020–
    36. Europe: Artificial
    37. Heart Market, by Type, 2020-2027 (USD Million)
    38. Europe: Artificial
    39. Heart Market, by End User, 2020-2027 (USD
      1. Million)
    40. Western Europe:
    41. Artificial Heart Market, by Type, 2020-2027 (USD
      1. Million)
    42. Western
    43. Europe: Artificial Heart Market, by End User, 2020–
    44. Eastern Europe: Artificial Heart Market, by Type, 2020-2027
      1. (USD
      2. Million)
    45. Eastern Europe: Artificial Heart Market, by End
      1. User, 2020–
    46. Asia-Pacific: Artificial
    47. Heart Market, by Type, 2020-2027 (USD
      1. Million)
    48. Asia-Pacific:
    49. Artificial Heart Market, by End User, 2020-2027
      1. (USD Million)
      2. Table
    50. Middle East & Africa: Artificial Heart Market, by Type, 2020-2027
      1. (USD
      2. Million)
    51. Middle East & Africa: Artificial Heart Market, by End
      1. User,
    52. LIST OF FIGURES
    53. Research Process
    54. Segmentation for Global Artificial Heart
      1. Market
    55. Segmentation Market Dynamics for Global Artificial Heart Market
    56. Global Artificial Heart Market Share, by Type, 2020
      1. Figure 5
    57. Global Artificial Heart Market Share, by End User, 2020
    58. Global Artificial
    59. Heart Market Share, by End User, 2020
    60. Global Artificial Heart Market
      1. Share, by Region, 2020
    61. North America: Artificial Heart Market Share,
      1. by Country, 2020
    62. Europe: Artificial Heart Market Share, by Country,
    63. Asia-Pacific: Artificial Heart Market Share, by Country, 2020
    64. Middle East & Africa: Artificial Heart Market Share, by Country,
      1. 201
    65. Global Artificial Heart Market: Company Share Analysis, 2020
      1. (%)
    66. SynCardia Systems, LLC: Key Financials
    67. SynCardia
      1. Systems, LLC.: Segmental Revenue
    68. SynCardia Systems, LLC: Geographical
      1. Revenue
    69. BiVACOR Inc.: Key Financials
    70. BiVACOR Inc.:
      1. Segmental Revenue
    71. BiVACOR Inc.: Geographical Revenue
      1. Figure
    72. CARMAT: Key Financials
    73. CARMAT: Segmental Revenue
      1. Figure 22
      2. CARMAT: Geographical Revenue
    74. ABIOMED: Key Financials
      1. Figure
    75. ABIOMED: Segmental Revenue
    76. ABIOMED.: Geographical Revenue

    Artificial Heart Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027